Results
|
5041.
|
|
|
5042.
|
|
|
5043.
|
|
|
5044.
|
|
|
5045.
|
|
|
5046.
|
|
|
5047.
|
|
|
5048.
|
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. [electronic resource] by
- Rini, Brian I
- Choueiri, Toni K
- Elson, Paul
- Khasawneh, Mohamad K
- Cotta, Claudiu
- Unnithan, Jaya
- Wood, Laura
- Mekhail, Tarek
- Garcia, Jorge
- Dreicer, Robert
- Bukowski, Ronald M
Producer: 20081023
In:
Cancer vol. 113
Availability: No items available.
|
|
5049.
|
|
|
5050.
|
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). [electronic resource] by
- Bellmunt, Joaquim
- Trigo, José Manuel
- Calvo, Emiliano
- Carles, Joan
- Pérez-Gracia, José L
- Rubió, Jordi
- Virizuela, Juan Antonio
- López, Rafael
- Lázaro, Martín
- Albanell, Joan
Producer: 20100416
In:
The Lancet. Oncology vol. 11
Availability: No items available.
|
|
5051.
|
|
|
5052.
|
|
|
5053.
|
Population pharmacokinetic analysis of sorafenib in patients with solid tumours. [electronic resource] by
- Jain, Lokesh
- Woo, Sukyung
- Gardner, Erin R
- Dahut, William L
- Kohn, Elise C
- Kummar, Shivaani
- Mould, Diane R
- Giaccone, Giuseppe
- Yarchoan, Robert
- Venitz, Jürgen
- Figg, William D
Producer: 20120102
In:
British journal of clinical pharmacology vol. 72
Availability: No items available.
|
|
5054.
|
|
|
5055.
|
|
|
5056.
|
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice? [electronic resource] by
- Sacco, Rodolfo
- Bargellini, Irene
- Ginanni, Barbara
- Bertini, Marco
- Faggioni, Lorenzo
- Federici, Graziana
- Romano, Antonio
- Bertoni, Michele
- Metrangolo, Salvatore
- Altomare, Emanuele
- Parisi, Giuseppe
- Tumino, Emanuele
- Scaramuzzino, Antonio
- Bresci, Giampaolo
- Bartolozzi, Carlo
Producer: 20130103
In:
Expert review of anticancer therapy vol. 12
Availability: No items available.
|
|
5057.
|
|
|
5058.
|
|
|
5059.
|
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program. [electronic resource] by
- Keir, Stephen T
- Maris, John M
- Lock, Richard
- Kolb, E Anders
- Gorlick, Richard
- Carol, Hernan
- Morton, Christopher L
- Reynolds, C Patrick
- Kang, Min H
- Watkins, Amy
- Houghton, Peter J
- Smith, Malcolm A
Producer: 20101116
In:
Pediatric blood & cancer vol. 55
Availability: No items available.
|
|
5060.
|
|